HEMATOPOIETIC NEOPLASM
Clinical trials for HEMATOPOIETIC NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily pill shrink the spleen in myelofibrosis?
Disease control TerminatedThis phase 3 trial is testing an experimental oral drug, SAR302503, in people with a rare bone marrow disorder called myelofibrosis who have an enlarged spleen. Participants are randomly assigned to receive one of two doses of the drug or a placebo. The main goal is to see if the…
Matched conditions: HEMATOPOIETIC NEOPLASM
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for myelofibrosis patients who stop responding to standard therapy
Disease control TerminatedThis phase 2 trial tests an experimental drug called SAR302503 in people with myelofibrosis who have already been treated with ruxolitinib. The main goal is to see if the drug can shrink the spleen by at least 35% after six months of daily oral capsules. The study also tracks whe…
Matched conditions: HEMATOPOIETIC NEOPLASM
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC